APOGEE ENTERPRISES, INC. (APOG): M&A transaction — Apogee closes $242M acquisition of UW Solutions; funds with $250M term loan draw

APOGEE ENTERPRISES, INC.

Acquired UW Interco (UW Solutions) for $242M cash; $1.75M placed in escrow for post-closing adjustments.
Drew $250M under existing term loan facility to finance purchase price and for working capital.
FY2025 expects ~$30M added net sales and ~$0.10 dilutive impact to adjusted diluted EPS.
FY2026 expects accretion with ~$100M revenue and ~20% adjusted EBITDA margin from the deal.
Acquisition expands Large-Scale Optical segment; CEO Silberhorn cites new growth engine.

item 2.03 item 2.01 item 1.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

APOGEE ENTERPRISES, INC. completed an acquisition involving UW Holdings, LLC (the "Seller") and UW Interco, LLC (the "Target") for $242 million (closed 2024-11-04).

Action: acquisition
Counterparty: UW Holdings, LLC (the "Seller") and UW Interco, LLC (the "Target")
Consideration: $242 million
Closing: 2024-11-04

Exact text from the filing

of the Purchase Agreement, the Company acquired all of the membership interests of the Target from the Seller in exchange for cash consideration (the “Closing”) in the amount of $242 million (the “Unadjusted Purchase Price”), of which $1.75 million was deposited into escrow in connection with the Purchase Agreement. The Unadjusted Purchase Price is subject to

View on SEC.gov

31 m&a transactions filed in the last 30 days. Browse all m&a transactions →

APOGEE ENTERPRISES, INC. filing history →

Source: SEC EDGAR

accession 0000006845-24-000268

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.